Country Correspondent: Margje Haverkamp

Holland’s Maastricht University Medical Center is collaborating with international partners in developing an artificial intelligence–based virtual system, known as Molly, to help patients with heart failure. Molly version 1.0, a virtual nurse, is already being used under supervision among a small group of patients with cardiomyopathy, a form of heart muscle disease. Molly measures their blood pressure and advises them when to contact their physicians. With EUR 4.5 million (USD 5.1 million) in funding, the group is now developing Molly 2.0, with the aim for Molly 2.0 to be able to independently diagnose diseases, recognize warning symptoms, prescribe medications, and request blood tests. Developers believe that Molly will be able to reduce unnecessary hospital admissions and thereby health care costs. Molly 2.0 is expected to be tested in a clinical environment in two years’ time.